ChromoTek anti-IFNy recombinant VHH, CoraLite ® Plus 647

CL647-IFNg is a recombinant CoraLite ® Plus 647 conjugated anti IFNg Nanobody (VHH) that targets IL6 in IF and FC applications, showing reactivity with human samples.
Cat No. CL647-IFNg

Host/Type

Alpaca VHH

Reactivity

Human

Applications

IF, FC

Conjugate

CoraLite® Plus 647

IFNg VHH, IFNg single domain antibody (sdAb), Interferon Gamma, Immune interferon, Interferon

SKU/Size: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Product Information

CL647-IFNg is a recombinant CoraLite ® Plus 647 conjugated anti IFNg Nanobody (VHH) that targets IL6 in IF and FC applications, showing reactivity with human samples.

ApplicationsIF, FC
ReactivityHuman
ConjugateCoraLite® Plus 647
TypeNanobody
ClassRecombinant
HostAlpaca
AffinityPicomolar range, below the assay limit (biolayer interferometry)
Molecular Weight14.8 kDa
FormLiquid
Excitation/Emission Maxima Wavelengths654 nm / 674 nm
RRIDAB_3665386
Storage Buffer10 mM HEPES pH 7.0, 500 mM NaCl, 5 mM EDTA, 0.09% sodium azide
Storage ConditionStore at -20°C
Shippingblue ice
BackgroundIFN gamma (IFNG) is a soluble cytokine that is the only member of the type II class of IFN. It is secreted by Th1 cells, cytotoxic T cells and NK cells. The cytokine is associated with antiviral, immunoregulatory and anti-tumor properties and is a potent activator of macrophages. It plays crucial roles in pathogen clearance. Aberrant IFNG expression is associated with a number of autoinflammatory and autoimmune diseases. It has been identified in many studies as a biomarker for pleural tuberculosis (TB).